Improved Glycemic Control during a One-Week Adventure Camp in Adolescents with Type 1 Diabetes-The DIACAMP Study

Biosensors (Basel). 2024 Sep 21;14(9):451. doi: 10.3390/bios14090451.

Abstract

Adolescence remains a crucial age associated with diabetes distress in individuals living with type 1 diabetes (T1D). The Austrian organization "Diabär" regularly hosts a one-week adventure camp for adolescents (12-18 years) living with T1D. The camp focuses on "fun activities" without a structured educational protocol in order to minimize diabetes distress and increase diabetes management skills. In contrast to educational camps, training is kept to a minimum. However, attendees analyze the glycemic data of the previous day with their medical supervisor once daily during the camp. All subjects used a standardized real-time continuous glucose monitoring (CGM) system (DexcomG7) throughout the whole study. Glycemic metrics were prospectively analyzed during three periods: week 1 = home phase, week 2 = adventure camp, and week 3 = after the camp. Safety (time below range 1 [TBR1], 69-54 mg/dL, and time below range 2 [TBR2], <54 mg/dL) and efficacy (time in range [TIR], 70-180 mg/dL) were assessed by comparing the CGM data during weeks 1-3. The CGM data of 14 participants were analyzed. The TIR was higher during the camp week versus week 1 (70.4 ± 11.1% vs. 53.1 ± 20.2%; p = 0.001). The TBR1 significantly increased during camp compared to week 1 (2.5 ±1.7% vs. 1.3 ± 1.2%; p = 0.009), whereas the TBR2 did not differ. No serious adverse events occurred. This adventure camp without a main focus on education showed feasibility and safety in adolescents with T1D.

Keywords: continuous glucose monitoring; diabetes camp; diabetes mellitus type 1.

MeSH terms

  • Adolescent
  • Blood Glucose Self-Monitoring
  • Blood Glucose*
  • Child
  • Diabetes Mellitus, Type 1* / drug therapy
  • Female
  • Glycemic Control*
  • Humans
  • Male

Substances

  • Blood Glucose

Grants and funding

Dexcom G7 sensors were sponsored free of charge by Dexcom Inc. (San Diego, CA, USA). Publication fees were covered by Verein zur Förderung der wissenschaftlichen Forschung am Wilhelminenspital, Montleartstraße 37, 1160, Vienna, Austria.